Predicting recurrence of respiratory failure in critically ill patients with COVID-19: A preliminary study

Coronavirus disease 2019 (COVID-19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), poses a serious global health threat. Clinical concerns include rapid deterioration of respiratory failure requiring mechanical ventilation, high mortality, and the possibility of reinfection after a successful recovery.1 Recently, COVID-19 relapse after transient improvement has emerged as a clinically relevant issue2,3,4; reports suggest that COVID-19-related inflammation can remain even when patients have seemingly improved.

Source: Journal of Infection - January 24, 2021 Category: Infectious Diseases Authors: Yuichi Adachi, Takayuki Shiroyama, Yuta Yamaguchi, Teruaki Murakami, Haruhiko Hirata, Saori Amiya, Takayuki Niitsu, Yoshimi Noda, Reina Hara, Takatoshi Enomoto, Takayoshi Morita, Yasuhiro Kato, Akinori Uchiyama, Yoshito Takeda, Atsushi Kumanogoh Tags: Letter to the Editor Source Type: research